Literature DB >> 20930299

Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease.

Isobel J Whitehouse1, Carolyn Jackson, Anthony J Turner, Nigel M Hooper.   

Abstract

The cellular form of the prion protein (PrPC) has been shown to inhibit the production of amyloid-β which is critically involved in the pathogenesis of Alzheimer's disease (AD). We examined the expression of PrPC by immunoblot analysis in the hippocampus and temporal cortex in sporadic AD, familial AD, and appropriate age-matched controls, and in an aging series (age 20 to 88 years) of brains. PrPC was reduced by 53% (p=0.032) in the hippocampus in sporadic AD as compared to the age-matched controls. No such reduction in PrPC was seen in familial AD. PrPC was reduced in the hippocampus with aging (rs=0.03). The reduction in PrPC in sporadic but not familial AD suggests that reduced PrPC expression reflects a primary mechanism of disease and is not merely a secondary consequence of other AD-associated changes. The reduction of PrPC in the brain with aging suggests that age-related decreases in PrPC may contribute to the increased incidence of AD in older people.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930299     DOI: 10.3233/JAD-2010-101071

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

1.  Regulation of amyloid-β production by the prion protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Nigel M Hooper
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 2.  Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.

Authors:  Jinghui Luo; Sebastian K T S Wärmländer; Astrid Gräslund; Jan Pieter Abrahams
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

3.  Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Herbert Baybutt; Debbie Brown; Katherine A B Kellett; Carolyn D Jackson; Anthony J Turner; Pedro Piccardo; Jean C Manson; Nigel M Hooper
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

4.  Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.

Authors:  Jo V Rushworth; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

5.  The role of zinc in Alzheimer's disease.

Authors:  Nicole T Watt; Isobel J Whitehouse; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

6.  The prion protein regulates beta-amyloid-mediated self-renewal of neural stem cells in vitro.

Authors:  Steven J Collins; Carolin Tumpach; Qiao-Xin Li; Victoria Lewis; Timothy M Ryan; Blaine Roberts; Simon C Drew; Victoria A Lawson; Cathryn L Haigh
Journal:  Stem Cell Res Ther       Date:  2015-04-11       Impact factor: 6.832

7.  Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy.

Authors:  Erin L Abner; Fanny M Elahi; Gregory A Jicha; Maja Mustapic; Omar Al-Janabi; Joel H Kramer; Dimitrios Kapogiannis; Edward J Goetzl
Journal:  FASEB J       Date:  2020-03-10       Impact factor: 5.191

8.  Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.

Authors:  Isobel J Whitehouse; J Scott Miners; Elizabeth B C Glennon; Patrick G Kehoe; Seth Love; Katherine A B Kellett; Nigel M Hooper
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Prion protein facilitates uptake of zinc into neuronal cells.

Authors:  Nicole T Watt; David R Taylor; Talitha L Kerrigan; Heledd H Griffiths; Jo V Rushworth; Isobel J Whitehouse; Nigel M Hooper
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Prion protein accumulation in lipid rafts of mouse aging brain.

Authors:  Federica Agostini; Carlos G Dotti; Azucena Pérez-Cañamás; Maria Dolores Ledesma; Federico Benetti; Giuseppe Legname
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.